Probiotic-guided CAR-T cells for solid tumor targeting

Vincent, Rosa L., Gurbatri, Candice R., Li, Fangda, Vardoshvili, Ana, Coker, Courtney, Im, Jongwon, Ballister, Edward R., Rouanne, Mathieu +7 more·2023·Science
DOI 10.1126/science.add7034

Cited by (273)

Items 101–200 of 273

  1. Tumor-Targeted Delivery of PD-1-Displaying Bacteriophages by Escherichia coli for Adjuvant Treatment of Colorectal Cancer
    Hongrui Li, Ying Qian Zhou, Bang‐Ce Ye · 2025 · ACS Synthetic Biology
  2. Synthetic biology strategies for engineering probiotics and commensal bacteria for diagnostics and therapeutics
    Jiwoo Nam, Yuna Lee, Sion Lee, Hyungjun Choi, Sang Yup Lee, Dongsoo Yang · 2025 · Biotechnology Advances
  3. Engineered probiotics recruit CAR macrophages and establish immune memory to eradicate heterogeneous glioblastoma in mice
    Yulin Zhang, Jianyu Shen, Yu Xu, Fan Feng, Xu Han, Kaiyan Xi, Zezheng Fang, Yi Zhang, Mingrui Wang, Zixu Wang et al. · 2026 · Cell Host & Microbe
  4. Engineering strategies to mitigate toxicities associated with CAR‐T cell therapy
    Tyler Wolter, Yixin Wang, Quan-Yin Hu · 2024 · BMEMat
  5. CAR T-cells for pediatric solid tumors: where to go from here?
    Tina Trautmann, Natalia Yakobian, Rosa Nguyen · 2024 · Cancer and Metastasis Reviews
  6. Probiotics: A New Approach for the Prevention and Treatment of Cervical Cancer
    Hui Li, Zhen Xu, Chaoqi Liu, Jinfang Deng, Ziqin Li, Yongqin Zhou, Zhiying Li · 2025 · Probiotics and Antimicrobial Proteins
  7. Advances in understanding therapeutic mechanisms of probiotics in cancer management, with special emphasis on breast cancer: A comprehensive review
    As Angel Nama, G Mary Sandeepa, Buddolla Viswanath, Anthati Mastan · 2025 · European Journal of Pharmacology
  8. Nanomaterial combined engineered bacteria for intelligent tumor immunotherapy
    Shurong Qin, Guanzhong He, Jingjing Yang · 2024 · Journal of Materials Chemistry B
  9. Combinatorial leaky probiotic for anticancer immunopotentiation and tumor eradication
    Chenghao Liu, Yi‐Chung Pan, See-Khai Lim, Chung‐Yuan Mou, Che‐Ming Jack Hu, Kurt Yun Mou · 2024 · Cell Reports Medicine
  10. Friends close, enemies closer: the complex role of the microbiome in antitumor immunity
    Dipyaman Patra, Gagan Dev, Timothy Wesley Hand, Abigail E. Overacre-Delgoffe · 2025 · Current Opinion in Immunology
  11. EGFR TKIs suppress MUC1 glycosylation through the PI3K/AKT/SP1/C1GALT1 pathway to enhance TnMUC1 CAR-T efficacy in EGFR-mutant NSCLC
    Ziwei Zhou, Si Emma Chen, Jianli Zhao, Xin Du, Haibin Yin, Chao Zhou, Hai Hu, Yunfang Yu, Yinghua Zhu, Herui Yao · 2025 · Cell Reports Medicine
  12. Communication between gut microbiota-derived metabolites and the tumor microenvironment
    Xinyi Hu, Bo Li, Yuanqing Li, Yushan Liang, Tingting Huang · 2025 · Frontiers in Immunology
  13. Attenuated Bacteria‐Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies
    Yucheng Liu, Junhong Yao, Jiaxin Deng, Minjie Zhou, Kaiyue Shen, Shishuo Sun, Xiaoge Gao, Qing Zhang, Haiheng Xu · 2026 · Advanced Science
  14. Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach
    Ofir Bar, Angel Porgador, Tomer Cooks · 2024 · Journal of Extracellular Biology
  15. Prospects of engineered bacteria-assisted CAR T Cell therapy in gastrointestinal cancers
    Qingqing Zhang, Xiao Song, Junhong Liu, Xuejiao Zhou · 2025 · Oncology Reviews
  16. The crosstalk between probiotics and T cell immunity
    Yuanyuan Liu, Xu Cao, Hongwei Liu, Wencan Zhang · 2025 · Frontiers in Immunology
  17. Nano-/nanobio-technology-enhanced CAR-T cell therapy: engineering the next generation of immunotherapies
    Maocheng Zuo, Junkang Wang, Wei Zhang, Lujia Xiao, Zi Qiao, Wenhao Li, Junqiao Zhao, Kun Xiong, Xuebing Yan, Kun Zhang · 2025 · Coordination Chemistry Reviews
  18. Advancing in vivo reprogramming with synthetic biology
    Farhana Islam, Mitchell R. Lewis, James D Craig, Peyton M. Leyendecker, Tara L. Deans · 2024 · Current Opinion in Biotechnology
  19. Chimeric Antigen Receptor Cells Solid Tumor Immunotherapy Assisted by Biomaterials Tools
    Yujie Song, Yifan Wang, Jianping Man, Yihua Xu, Guangming Zhou, Wenhao Shen, Yu Chao, Kai Yang, Pei Pei, Lin Tao Hu · 2025 · ACS Applied Materials & Interfaces
  20. Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer Immunotherapy
    Gabriela Christina Kuhl, Mark Tangney · 2025 · Cancers
  21. Resynthesis of synthetic biology techniques: combining engineered bacteria with other antitumour therapies
    Xueke Chang, Xiaolin Liu, Xiumei Wang, Lin Ma, Jing Liang, Yan Li · 2025 · Frontiers in Microbiology
  22. Engineered nano-bacteria hybrids for precision cancer immunotherapy
    Liang Yu, Yulin Qiu, Rutian Li, Zhen Cheng Xu, Rutian Li · 2025 · Materials Today Bio
  23. HBsAg-tagged tumour vaccine system eliminates solid tumours through virus-specific memory T cells
    Wenguang Wang, Ya Chu, Lili Zhao, Miao Lv, Luyao Wang, Fangfei Jin, Kaiyuan Hu, Lihang Cen, Shuang Qin, Xianjing Li et al. · 2025 · Nature Biomedical Engineering
  24. Microbial medicines: Unlocking the therapeutic potential of the microbiome in cancer treatment
    Abram Canowitz, Nitin H. Kamble, Nathan Muck, Komalpreet Kaur, Nathaniel Garay, Priyanka Bellala, Bhavesh Babulal Gabani, Nalinikanth Kotagiri · 2026 · Journal of Controlled Release
  25. Engineered Bacterial Biomaterials for Augmenting Adoptive Immune Cell Therapy Against Solid Tumors
    Chaojie Zhu, Zhongquan Sun, Qian Wu, Feifan Wang, Lingxiao Louis Zhang, Wei Wang, Yuan Ding, Hongjun Li · 2026 · Advanced Materials
  26. Engineering advanced bacterial therapy for tumor and inflammatory diseases
    Yuanyuan Chen, Qiuju Han · 2025 · International Journal of Pharmaceutics
  27. pH-responsive activation of Tet-On inducible CAR-T cells enables spatially selective treatment of targeted solid tumors at reduced safety risk
    Yan Liu, Yu Hao, Jin Zhang, Mengmeng Zhang, Jiahui Chen, Zhengmiao Xia, Minming Chen, Xiang Lv, Xinxing Ma, Yehui Zhou et al. · 2025 · National Science Review
  28. Microbiome unlocks cancer immunotherapeutic potential: State of the art and future
    Han-Yue Luo, Lei‐Ming Cao, Kan Zhou, Yao Xiao, Zi‐Zhan Li, Bing Liu, Lin‐Lin Bu · 2025 · Seminars in Cancer Biology
  29. Repurposing the bacterial surface display technology for drug delivery
    Shaobo Yang, Mengdi Yang, Maria Jennings, Hania Timek, Amber E. Haley, Rizwan Romee, Jiahe Li · 2025 · Advanced Drug Delivery Reviews
  30. Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery
    Yixin Wang, Edikan A. Ogunnaike, Huan Min Yang, Sichen Yuan, Rachel Hong, Allie Barrett, Emem Ebong, Bo Liu, Gianpietro Dotti, Quanyin Hu · 2025 · Proceedings of the National Academy of Sciences
  31. Intratumoral Microbiome: Impact on Cancer Progression and Cellular Immunotherapy
    Georgy E. Leonov, Antonina Vladimirovna Starodubova, Oleg V. Makhnach, Dmitry Vadimovich Goldshtein, Diana I. Salikhova · 2025 · Cancers
  32. Unraveling the potential of bioengineered microbiome-based strategies to enhance cancer immunotherapy
    Muhammad Hamza, Shuai Wang, Yike Liu, Kun Li, Motao Zhu, Lin Chen · 2025 · Microbiological Research
  33. Programming megakaryocytes to produce engineered platelets for delivering non-native proteins
    Farhana Islam, Shwan B. Javdan, Mitchell R. Lewis, James D. Craig, Han Wu, Tara L. Deans · 2025 · Communications Biology
  34. Microbiota mechanisms in cancer progression and therapy
    Xing Zhang, Kyong Tkhe Fam, Tingting Dai, Howard C. Hang · 2025 · Cell chemical biology
  35. Exploring novel strategies of oncolytic viruses and gut microbiota to enhance CAR-T cell therapy for colorectal cancer
    Jia Yi, Sangmu Quji, Luxuan Guo, Zhongqiu Chai, Xianbin Kong, Jingyan Meng · 2025 · Cellular Immunology
  36. Near-infrared activatable engineered bacteria for synergistic cancer photo-immunotherapy
    Qinglian Hu, Ying He, Zhuoting Lu, Xikai Zhang, Jie Liu, Yuanxiang Jin · 2025 · Chemical Engineering Journal
  37. The Impact of Microbiome on Breast Cancer and Regulatory Strategies
    Jiaxin Wang, Dongyan Xu, Shiyao Hu, Beiwen Zheng, Yiding Chen, Tao Pan · 2025 · Microorganisms
  38. Transmembrane DNA Nanochannel-Engineered Artificial Receptors for Navigating NK Cell Immunotherapy in Solid Tumors
    Danyu Wang, Hua Yi, Jiali Zhang, Mengyu Huang, Yue Qiu, Yang Wang, Peiru Chen, Чан Лю, Tingyi Xu, Qiuxia Yang et al. · 2026 · Journal of the American Chemical Society
  39. Shaping death: how the microbiome regulates tumour cell demise and therapy response
    Martina Raudenská, Jan Balvan, Eliška Zgarbová, David Kalfeřt, Jan Plzák, Michal Masařík · 2026 · Cancer and Metastasis Reviews
  40. Biomimetic Cell Membrane‐Coated MOFs System for Targeted Cancer Therapy
    Qilu Wu, Jia Song Deon Chon, Yuxiao Feng, Kang Liang, S. Li, Can Yang Zhang, Jun Ge · 2026 · Advanced Science
  41. From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine
    Liyuan Qiao, Leyang Wu, Yihan Xiao, Jiahui Qiu, Xinyue Qiao, Xiao Dong, Chengxuan Lei, W Wang, Yuzi Zhao, Zichun Hua · 2026 · Journal of Hematology & Oncology
  42. Chimeric antigen receptor T cell immunotherapy for gynecological malignancies
    Yajuan Gao, Jing Na He, Jing Wang, Haiou Xu, Lin Ma · 2025 · Critical Reviews in Oncology/Hematology
  43. Bacterial Autonomous Intelligent Microrobots for Biomedical Applications
    Haotian Chen, Yingze Li, Zhenguang Li, Yuantai Sun, Weicheng Gu, Chang Chen, Yu Cheng · 2025 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  44. An engineered microbial nanohybrid for enhanced photothermal-chemodynamic therapy through controlled gas generation
    Shujing Xu, Yuewei Li, Jiansen Li, Suixin Xing, Xinlu Zhang, Xu Zhang, Lei Han, Sheng Wang · 2025 · Journal of Colloid and Interface Science
  45. Multiplexed ultrasound imaging of gene expression
    2025
  46. Bioactive-material-programmed CAR-T cell living drug for augmented immunotherapy against tumors
    Guojun Huang, Zhongliang Tang, Ting Yin, Ai-Qing Ma, Han Gong, Yuhui Zhang, Hong Pan, Lintao Cai · 2024 · Cell Reports Physical Science
  47. Hidden Partner of Immunity: Microbiome as an Innovative Companion in Immunotherapy
    Pyoseung Kim, Sunggeun Joe, Heeyoung Kim, Hyejeong Jeong, Sunghwan Park, Jihwan Song, Wondong Kim, Yong Gu Lee · 2025 · International Journal of Molecular Sciences
  48. Synthetic bacteria with programmed cell targeting and protein injection suppress tumor growth in vivo
    Alejandro Asensio‐Calavia, Carmen Mañas, Alba Cabrera-Fisac, Eva Pico-Sánchez, Elena M. Seco, Starsha A. Kolodziej, Daniel S. Leventhal, José M. Lora, Beatriz Álvarez, Luis Ángel Fernández · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Probiotics: From natural to artificial
    Li-Hua Liu, Xianhong Zhang, Ying Huang, Rongrong Chen, Junyang Huang, Shuqi Wang, Wei Li, Ao Jiang · 2026 · Biotechnology Advances
  50. The challenges and progress of CAR-T cell therapy in the treatment of solid tumors
    Kai Cui, Wanjun He, Na Huang, Songshan Zhu, Dan Jiang, Weiqiang Yang, Yiwei Zeng, Muhammad Asad Farooq, Guangxian Xu · 2025 · Molecular and Cellular Biochemistry
  51. Microbial Systems Enhancing CAR-Based Therapies: A Synthetic Biology Paradigm for Next-Generation Cancer Immunotherapy
    Sanjay Gottipamula, Raviraja Neelavar Seetharam, Sameer Kumar Singdevsachan, Murugesan Sathya · 2025 · Current Microbiology
  52. Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy
    Fengxue Li, Lili Qiao, Xinquan Liang, Yingying Zhang, Ning Liang, Jian Xie, Guodong Deng, Yuying Hao, Pingping Hu, Xue Wu et al. · 2026 · Cancer Medicine
  53. Dual‐Key Genetic Circuit Enables Stable and Self‐Regulated Engineered Bacteria for the Treatment of Ulcerative Colitis
    Shuaijie Ding, Biao Yang, Xinyu Li, Yi Wang, Chun‐Yao Huang, Wenfei Dong, Wei Xie · 2026 · Advanced Science
  54. Living Microbial Drugs
    Cemile Elif Özçelik, Nazlıcan Tunç, Senem Şen, Urartu Özgür Şafak Şeker · 2026 · Chemistry - A European Journal
  55. Intratumoral microbiota in cancer: molecular mechanism and therapeutic strategies
    Yao Yu, Ziyu Guo, Zehao Luo, Yating Dian, Xiaoxin Yang, Xiang Chen, Furong Zeng, Guangtong Deng · 2026 · Molecular Biomedicine
  56. Engineering commensal microbes for host health
    Elizabeth A. Brown, Arianna Brevi, David M. Zong, Amir Zarrinpar · 2026 · Cell Host & Microbe
  57. Precise construction of DNA origami‐based materials for functional regulation on biological interface
    Yushuai Wu, Xiaohui Wu, Run Tian, Yiming Wang, Baoquan Ding, Qiao Jiang · 2024 · Smart Molecules
  58. Advanced strategies in improving the immunotherapeutic effect of CAR‐T cell therapy
    Minmin Wang, Linzi Jia, Xiangpeng Dai, Xiaoling Zhang · 2024 · Molecular Oncology
  59. Cascade Enzymes Confined in DNA Nanoanchors for Antitumor Therapy
    Danyu Wang, Xin Mu Zhou, Mengyu Huang, Jie Duan, Yue Qiu, Hua Yi, Yang Wang, Huimin Xue, Jiali Zhang, Qiuxia Yang et al. · 2024 · ACS Applied Materials & Interfaces
  60. The road ahead for chimeric antigen receptor T cells
    Carli M. Stewart, Elizabeth L. Siegler, Saad S. Kenderian · 2025 · The Journal of Immunology
  61. Engineered bacteria assist CAR-cell immunotherapy
    Tianyu Shao, Manman Xu, Jie Li, Xiao Zhao · 2025 · Acta Pharmaceutica Sinica B
  62. Chimeric antigen receptor natural killer cell therapy for solid tumors: mechanisms, clinical progress, and strategies to overcome the tumor microenvironment
    Xiang Min Yu, Jiayi Dong, Lijuan Shao, Size Chen · 2025 · Experimental Biology and Medicine
  63. Temporal gene regulation enables controlled expression of gas vesicles and preserves bacterial viability
    Zongru Li, Chia-Yu Ho, Diana Barr, Sumin Jeong, Lihua Ma, George J. Lu · 2025 · Nature Communications
  64. Antigen-specific activation of gut immune cells drives autoimmune neuroinflammation
    Lena K. Siewert, Kristina Berve, Elisabeth Pössnecker, Julia Dyckow, Amel Zulji, Ryan Baumann, Aida Muñoz-Blázquez, Gurumoorthy Krishnamoorthy, David Schreiner, Sharon A. Sagan et al. · 2025 · Gut Microbes
  65. Rational engineering of combinatorial bacterial therapies for cancer
    Paige Steppe, Katherine O’Connor, Jeff Hasty · 2026 · Genome biology
  66. Roles of the gut microbiota in cancer immunotherapy: Mechanistic foundations and therapeutic opportunities
    Qinglin Wu, Yi-Ran Zhou, Zi-rong Chen, Ming-Xin Liu, Meng-Xin Liu, Yi-Fei Liu, Zhishu Li, Qi-Rui Zhao, Yong-Qian Zhang, H. Zhang et al. · 2026 · Critical Reviews in Oncology/Hematology
  67. Microbiota-targeted nanoplatforms for colorectal cancer immunotherapy
    Shu-Qiang Li, Jia-Ning Wang, Sheng-Nan Zhao, Ge Feng, Ying-Dong Sun · 2026 · Pharmacological Research
  68. Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives
    Jiawei Chen, Yupan Bai, Lu Shen, Jiacheng Ying, J Q Xu, Jiayin Tang, Yu-Jie Bao · 2026 · MedComm
  69. Engineered microbe-based micro/nanorobots for interventional therapy of luminal cancers
    Li Wang, Tianze Du, Nana Ran, Yong Kang, Xiaoyuan Ji · 2026 · Medicine Plus
  70. Application of Synthetic Antigen-Encoded Escherichia coli Nissle 1917 Probiotic-Guided PD-1/CD28 Receptor-Integrated CAR-T Cell Therapy as Targeted Therapy for Colorectal Cancer: A Literature Review
    Tegar Raharja ARIAWAN, I G Mahapraja Divasta, Asri BINTARI, Bryan Gervais de Liyis, Desak Made Wihandani · 2025 · Journal of Oncological Sciences
  71. CAR T cells for solid tumors – developments to watch in 2023
    Marcel P. Trefny, S. Kobold · 2024 · Expert Opinion on Biological Therapy
  72. A Switch Protein Adapter for Anti‐LILRB4 CAR‐T Cells
    Ryan B. Huang, Heyu Chen, Jingjing Xie, Qi Lou, Lingxiao Tan, Ningyan Zhang, Zhiqiang An, Samuel John, Cheng Cheng Zhang · 2024 · European Journal of Immunology
  73. Nano-immunotherapy: Merging immunotherapy precision with nanomaterial delivery
    Nguyễn Thị Thanh Hà, Soumya Menon, Adolfo Rivero‐Müller · 2025 · iScience
  74. Microbes in regenerative medicine: A narrative review
    Vamshi Varaganti, Vishnu Avr, Naidu P Vedanth, Ridhi Chowdary Pusuluri, Abhinav Chandra Panniru, Sakshitha Potluri, Venkataramana Kandi · 2025 · Regenerative medicine reports .
  75. Bioorthogonal optimized virus immuno-nanomedicine (BOVIN)
    Wenchang Peng, Yajing Du, Luna Cui, Yi Xiao, Lavonda Li, Lijie Yan, Yun Gu, Lulu Zhang, Bowen Li, Zhiyun Wang et al. · 2025 · Nature Communications
  76. Synthetic biology-driven microbial therapeutics: Integrated platforms for disease diagnosis and intervention
    Fangyuan Ye, Hao Zheng · 2025 · Health engineering.
  77. CAT‐BLAST: Engineered bacteria for robust targeting and elimination of cancer‐associated fibroblasts
    Mengdi Xu, Ehsan Hashemi, Hui Gao, Qumar Zaman, Yi Ma, Jufang Wang, Wenjun Mao, Zhuobin Liang · 2026 · iMeta
  78. Shaping the Tumor Microenvironment: Insights from Host–Microbiota Interactions
    Khiem Chi Lam, Romina S. Goldszmid · 2026 · Cancer Discovery
  79. Advances in the combined treatment of solid tumors with nanodelivery systems based on engineered bacteria-TME modulation
    Bingjie Guo, Zhaokai Li, Yahui Wang, Baojuan Li, Junyi Zhou, Hang Chen, Meichai Li, Youfa Xu, Xin Wu · 2026 · Colloids and Surfaces B Biointerfaces
  80. Harnessing engineered bacteria for revolutionizing cancer immunotherapy
    Kan Zhou, Lei‐Ming Cao, Han-Yue Luo, Kang-Ning Wang, Zhiyong Song, Lin‐Lin Bu · 2026 · Advanced Composites and Hybrid Materials
  81. Intelligent plant exosomes synergize miRNAs and cisplatin for spatiotemporally precise multimodal treatment for TNBC with high safety
    Xi-Yuan Xu, Xuan Zhang, Yiyi Wang, Qi-Yao Xiao, Cheng Yang, Desheng Kong, Li‐Hua Peng · 2026 · Bioactive Materials
  82. Bibliometric analysis of genetically engineered bacteria in tumor therapy
    Yanmei Zhu, Yilin Yin, Yaqi Li, Qinghua Wang, Yu Chen, Ke Gu, Rui Yang, Min Zhou, Daozhen Chen · 2026 · Frontiers in Microbiology
  83. Engineered commensal Bacteroides thetaiotaomicron enables targeted drug delivery to colorectal tumors
    Xiaoyu Jia, Yuna Xu, Xinyu Liu, Meng Ye, Feng Wang, Xiaobing Yang, Xiangdong Gao, Juping Yu, Wei Liu · 2026 · Journal of Controlled Release
  84. Overcoming intratumoral transport barriers: Advances in local immunotherapy delivery platforms
    Madison A. Deeson, Corrine Ying Xuan Chua, Alessandro Grattoni · 2026 · Advanced Drug Delivery Reviews
  85. The trinity of T cell engagement: navigating the molecular and clinical landscape of CAR-T, TILs, and TCEs in the war against cancer
    Qiang Yang, Shaobin Wang, Fanlin Liu, Yongli Yu, Hongyun Zhao · 2026 · Frontiers in Immunology
  86. Toward oral nanomaterial-based drug delivery systems for hepatocellular carcinoma therapy: evidence mapping, route-specific validation, and translational challenges
    Fu Y, Yuanxin Ge, Shixiong Yi, Qifeng Peng, Heng Jiang, Jie Zhou · 2026 · Frontiers in Pharmacology
  87. Engineered bacteria-mediated augmentation of sialoglycan degradation strategy and immunogenic chemotherapy to boost effective cancer therapy
    Lizhen Liang, Zixuan Ye, Jiayi Wu, Huazhen Lu, Wenzheng Liu, Lingtong Meng, Yanan Li, He Huang · 2024 · Chemical Engineering Journal
  88. Genomic investigation of innate sensing pathways in the tumor microenvironment
    Gabriella M. Quinn, Gianna Maggiore, Bo Li · 2024 · BMC Cancer
  89. Tumor-Specific Antigen Delivery for T-cell Therapy via a pH-Sensitive Peptide Conjugate
    Annali M. Yurkevicz, Yanfeng Liu, Samuel G. Katz, Peter M. Glazer · 2024 · Molecular Cancer Therapeutics
  90. In silico assessment of CAR macrophages activity against SARS-CoV-2 infection
    Antonino Amoddeo · 2024 · Heliyon
  91. Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers
    Hongli Gao, Lianyue Qu, Mu Li, Xin Guan, Shuang Zhang, Xin Deng, Jin Wang, Fei Xing · 2025 · International Journal of Biological Macromolecules
  92. Antigen‐Targeting Inserted Nanomicelles Guide Pre‐Existing Immunity to Kill Head and Neck Cancer
    Lizhuo Zhang, Qingqing Feng, Chuanming Zheng, Y L Li, Xinyang Ge, Tiefeng Jin, Gaofeng Hu, Zhuo Tan, Jiafeng Wang, Jiajie Xu et al. · 2025 · Advanced Science
  93. Advances in the Application of Bacteria in Tumor Therapy
    媛 张 · 2024 · Hans Journal of Biomedicine
  94. CIMT 2024: Report on the 21st Annual Meeting of the Association for Cancer Immunotherapy
    Yasemin Ahrberg, Julia Dallmann, Janina Freitag, Abdulrizak Hassan, Christina Jung, Johanna Kiefer, Anindhita Meena Muralidharan, Matthias Peter, Jan David Beck · 2024 · Human Vaccines & Immunotherapeutics
  95. Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy
    Mathieu Rouanne, Noah Chen, Dylan L. Mariuzza, Fangda Li, Kenia de los Santos, Thomas M. Savage, Rosa L. Vincent, Cathy Lee Mendelsohn, Tal Danino, Nicholas Arpaia · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  96. A risk model based on signature genes predicts prognosis and associates with tumor immunity, drug sensitivity in breast cancer
    Yuan Li, Hao Li, Jichuan Quan, Ping Bi, Xuemei Liu, Yanwei Yao, Yanqin Peng, Congrui Wang, Xiaofang Gao, Junfang Duan et al. · 2025 · Cancer Biomarkers
  97. Integrating Microorganism-Based Therapy and Emerging Biotechnology in the Treatment of Intracranial Central Nervous System Diseases
    Z J Li, Shihua Yang, Li‐Da Su · 2025 · Pharmaceutics
  98. Strategies for engineering domesticated and undomesticated human microbes
    Dake Liu, Meng-Lun Hsieh, Yousong Ding · 2025 · Current Opinion in Biotechnology
  99. Recent advances in immunotherapy for breast cancer
    Yi Maggie Guo, Gang Zheng, Fan Yu, Liangchang Li, Yang Sun · 2025 · Discover Oncology
  100. Engineered bacteria/bacterial components strategy for glioma
    Yan Zhu, Meilin Shen, Qi Chen, Huanghao Yang · 2025 · Chemical Engineering Journal